Cellular proliferation characteristics of basal cell carcinoma: Relationship to clinical subtype and histopathology

European Journal of Surgical Oncology

Volumn 23, Issue 3, 1997, Pages 247-252

  Horlock, N M ^a   Wilson, G D ^a   Daley, F M ^a   Richman, P I ^a   Sanders, R ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

Basal cell carcinoma; Histological growth pattern; Immunohistochemistry; Ki 67

Indexed keywords

KI 67 ANTIGEN;

ARTICLE; BASAL CELL CARCINOMA; CANCER CLASSIFICATION; CELL DIFFERENTIATION; CELL PROLIFERATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR VOLUME;

EID: 0030748772     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(97)92508-7     Document Type: Article

References (29)

1. Miller SJ, Biology of basal cell carcinoma (Part I). J Am A cad Dermatol 1991; 24: 1-13.
2. Ten-Seldam REJ, HE. Histological typing of skin tumours. In: Geneva: World Convention. World Health Organization. 1974: 48-9.
3. Rowe DE, Carroll RJ, Day CL, Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989; 15: 315-28.
4. Robinson JK. Risk of developing another basal cell carcinoma. A 5-year prospective study. Cancer 1987; 60: 118-20.
5. Dixon AY, Lee SH, McGregor DH. Histologic features predictive of basal cell carcinoma recurrence: results of a multivariate analysis. J Cutan Pathol 1993; 20: 137-42.
6. Sloane JP. The value of typing basal cell carcinomas in predicting recurrence after surgical excision. Br J Dermatol 1977 96: 127-32.
7. Sexton M, Jones DB, Maloney ME. Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms. J Am Acad Dermatol 1990; 23: 1118-26.
8. Hauben DJ, Zirkin H, Mahler D, Sacks M. The biologic behavior of basal cell carcinoma: analysis of recurrence in excised basal cell carcinoma: part II. Plast Reconstr Surg 1982; 69: 110-6.
9. Dellon AL, DeSilva S, Connolly M, Ross A. Prediction of recurrence in incompletely excised basal cell carcinoma. Plast Reconstr Surg 1985; 75: 860-71.
10. Quinn AG, Sikkink S, Rees JL. Basal cell carcinomas and squamous cell carcinomas of human skin show distinct patterns of chromosome loss. Cancer Res 1994; 54: 4756-9.
11. Farndon PA, Del Mastro RG, Evans DG, Kilpatrick MW. Location of gene for Gorlin syndrome. Lancet 1992;339: 581-2.
12. Weinstein GD, Frost P. Cell proliferation in human basal cell carcinoma. Cancer Res 1970; 30: 724-8.
13. Stamp GW, Nasim M, Cardillo M, Sudhindra SG, Lalani EN, Pignatelli M. Transforming growth factor-beta distribution in basal cell carcinomas: relationship to proliferation index. Br J Dermatol 1993; 129: 57-64.
14. Wilson GD. Assessment of human tumour proliferation using bromodeoxyuridine - current status. Acta Oncol 1991; 30: 903-10.
15. Baum HP, Meurer I, Unteregger G. Ki-67 antigen expression and growth pattern of basal cell carcinomas. Arch Dermatol Res 1993; 285: 291-5.
16. Barnard NJ, Hall PA, Lemoine NR, Kadar N. Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables. J Pathol 1987; 152: 287-95.
17. Fogt F, Vortmeyer AO, Tahan SR. Nucleolar organizer regions (AgNOR) and Ki-67 immunoreactivity in cutaneous melanocytic lesions. Am J Dermatopaihol 1995; 17: 12-7.
18. Porschen R, Kriegel A, Langen C, et al. Assessment of proliferative activity in carcinomas of the human alimentary tract by Ki-67 immunostaining. Int J Cancer 1991; 47: 686-91.
19. Wong FW. Immunohistochemical detection of proliferating tumor cells in cervical cancer using monoclonal antibody Ki-67. Gynecol Obstet Invest 1994; 37: 123-6.
20. Ogawa Y, Inomata T, Nishioka A, et al. Changes in the Ki-67 labelling rates of head and neck squamous cell carcinomas during preoperative radiation therapy. Oncology 1992; 49: 450-3.
21. Silvestrini R. Cell kinetics: prognostic and therapeutic implications in human tumours. Cell Proliferation 1994: 27: 579-96.
22. Morales Ducret CR, van de Rijn M, LeBrun DP, Smoller BR. bcl-2 expression in primary malignancies of the skin. Arch Dermatol 1995; 131: 909-12.
23. Mealy E, Angus B, Lawrence CM, Rees JL. Prognostic value of Ki67 antigen expression in basal cell carcinomas. Br J Dermatol 1995; 133:737-41.
24. Wilson GD, Dische S, Saunders MI. Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy. Radiother Oncol 1995; 36: 189-97.
25. Franchimont C, Pierard GE, Van Cauwenberge D, Damseaux M, Lapiere CH. Episodic progression and regression of basal cell carcinomas. Br J Dermatol 1982; 106: 305-10.
26. Lever WF. Pathology of common skin tumors. J Surg Oncol 1971; 3: 235-50.
27. Emmett AJ. Surgical analysis and biological behaviour of 2277 basal cell carcinomas. Aust N Z J Surg 1990; 60: 855-63.
28. Wade TR, Ackerman AB. The many faces of basal-cell carcinoma. J Dermatol Surg Oncol 1978; 4: 23-8.
29. Thackary AC, Histological classifications of rodent ulcers and its bearing on their prognosis. Br J Cancer 1951; 5: 213-24.